Form 4: Vita Coco CSO Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report


Vita Coco's Chief Sales Officer, Charles van Es, exercised stock options and subsequently sold 20,000 shares of common stock under a pre-arranged trading plan.

Summary

  • Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported transactions on November 17, 2025.
  • Exercised 20,000 non-qualified stock options at an exercise price of $10.178 per share.
  • Subsequently sold 20,000 shares of common stock at a price of $50 per share.
  • These transactions were conducted under a Rule 10b5-1 trading plan.
  • Following these transactions, Mr. van Es directly owns 84,328 shares of common stock.
  • He also holds various non-qualified stock options with exercise prices ranging from $10.178 to $33.36, with different vesting schedules and expiration dates.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (exercise and sale) conducted under a Rule 10b5-1 plan, which is a common practice for executive compensation and personal financial management. It does not inherently signal strong positive or negative sentiment about the company's future prospects.

Positives

  • The Chief Sales Officer exercised options, indicating value in the company's stock.
  • The sale price of $50 per share is significantly higher than the exercise price of $10.178, demonstrating a substantial gain for the insider.
  • The transaction was executed under a Rule 10b5-1 trading plan, which suggests a pre-planned, non-discretionary sale, often mitigating concerns about opportunistic insider selling.

Negatives

  • An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived as a lack of confidence, although it is often for personal financial planning.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider transaction and does not provide information related to broader industry trends or competitors.

Stakeholder Impact

  • Shareholders: Provides transparency regarding insider trading activity. The sale under a 10b5-1 plan is generally viewed as less impactful than discretionary sales.
  • Management: Charles van Es, Chief Sales Officer, has monetized a portion of his equity compensation.

Next Steps

  • Continued vesting of various non-qualified stock options on their respective anniversary dates, provided continuous service.

Key Dates

DateDescription
11/27/2022Start of vesting for a non-qualified stock option (4 equal annual installments).
03/10/2024Start of vesting for a non-qualified stock option (4 equal annual installments).
03/04/2025Start of vesting for a non-qualified stock option (4 equal annual installments).
08/15/2025Start of vesting for a non-qualified stock option (3 equal annual installments).
11/17/2025Transaction Date for option exercise and stock sale.
02/10/2030Expiration Date for a fully vested non-qualified stock option.
01/11/2031Expiration Date for a fully vested non-qualified stock option.
10/21/2031Expiration Date for a non-qualified stock option.
08/15/2032Expiration Date for a non-qualified stock option.
03/10/2033Expiration Date for a non-qualified stock option.
03/04/2034Expiration Date for a non-qualified stock option.
03/04/2035Expiration Date for a non-qualified stock option.

Keywords

Vita Coco, COCO, Insider Trading, Form 4, Stock Options, Rule 10b5-1, Executive Compensation, Chief Sales Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.